Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Dosing Systems in Paediatrics
2013-004655-21Phase 2Terminated
- Sponsor
- Kern Pharma
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fentanyl in pain and Sedation requirement, sponsored by Kern Pharma. Primary endpoint: Determination of the basic population pharmacokinetic model. Started Apr 2014; status: terminated.
02
Drugs
fentanyl
03
Conditions
painSedation requirement
Beyond the preview
Go deeper on 2013-004655-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004655-21.